ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
2,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
4,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
7,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
8,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
9,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
10,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
11,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
12,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
13,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
13,2,Spinal cord paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
14,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
15,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,Y
16,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
16,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
16,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
19,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
20,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
21,1,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
22,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
23,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
24,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
25,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
25,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
25,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
25,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
25,5,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
25,6,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
26,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
26,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
26,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
26,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
26,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
26,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
26,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
27,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
28,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
28,2,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
29,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
30,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
31,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
31,2,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
31,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
32,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
32,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
33,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
33,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
34,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
35,1,Hypoplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
36,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
36,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
37,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
37,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
38,1,Infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
38,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
39,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
40,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
41,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
42,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
43,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
43,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
43,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
44,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
45,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
45,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
45,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
45,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
46,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
47,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
48,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
49,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
50,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
50,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
50,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
50,4,Xerophthalmia,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
51,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
52,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
53,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
53,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
54,1,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
55,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
56,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
56,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
57,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
58,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
59,1,Smear cervix abnormal,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
60,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
61,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
62,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
63,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
63,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
63,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
64,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
64,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
64,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
65,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
65,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
65,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
65,4,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
65,5,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
65,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
65,8,Quadriplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
65,9,Radiation myelopathy,Radiation injuries,Injuries by physical agents,Inj&P,N
65,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
65,11,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
66,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
67,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
68,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
68,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
68,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
69,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
69,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
69,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
70,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
70,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
70,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
71,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
72,1,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
72,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
73,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
74,1,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
75,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
76,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
77,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
78,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
79,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
80,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
81,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
81,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
81,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
81,4,Marrow hyperplasia,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
82,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
82,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
82,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
82,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
82,5,Marrow hyperplasia,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
83,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
83,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
83,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
83,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
83,5,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
84,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
84,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
84,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
84,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
84,5,Liver tenderness,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
84,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
84,7,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
85,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
86,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
86,2,Liver tenderness,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
86,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
86,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
86,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
86,6,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
87,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
87,2,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
88,1,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,Y
89,1,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
89,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
89,3,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,Y
90,1,Angiotensin converting enzyme decreased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
90,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
90,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
90,4,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
90,5,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
90,6,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
90,7,Granulomatous liver disease,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
90,8,Liver palpable,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
90,9,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
90,10,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
90,11,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
90,12,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
91,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
91,2,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
91,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
91,4,Acid fast bacilli infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
91,5,Bacterial test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
91,6,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
91,7,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
91,8,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
91,9,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
91,10,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,11,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,N
91,12,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
91,13,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
91,14,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
91,15,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
91,16,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
91,17,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
91,18,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
91,19,Purulence,Infections NEC,Infections - pathogen unspecified,Infec,N
91,20,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
91,21,Systemic inflammatory response syndrome,Inflammations,General system disorders NEC,Genrl,N
91,22,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
92,1,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
92,2,CSF test abnormal,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
92,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
92,4,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
92,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
92,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
92,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
92,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
92,9,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
92,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
93,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
93,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
93,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
94,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
95,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
96,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
96,2,Candida pneumonia,Candida infections,Fungal infectious disorders,Infec,N
96,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
96,4,Engraft failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
97,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
97,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
97,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
97,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
98,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
99,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
99,2,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
99,3,Cystitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
99,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
99,5,Human polyomavirus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
99,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
99,7,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
99,8,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
99,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
99,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
99,11,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
100,1,Arterial haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
100,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
100,3,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
100,4,Systemic mycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
100,5,Tracheostomy malfunction,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
101,1,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
102,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
103,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
103,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
104,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
104,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
105,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,3,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
106,1,Anti-thyroid antibody positive,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
107,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
107,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
108,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
109,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
109,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
110,1,Cytomegalovirus test,Virus identification and serology,Microbiology and serology investigations,Inv,N
111,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
111,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
112,1,Anti-thyroid antibody positive,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
112,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
113,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
113,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
113,3,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
114,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
115,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
116,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
117,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
118,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
118,2,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
119,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
120,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
120,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
121,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
122,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
122,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
122,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,4,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
123,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
123,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
124,1,Complications of bone marrow transplant,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
124,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
125,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
125,2,Complications of bone marrow transplant,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
125,3,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
125,4,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
126,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
126,2,Complications of bone marrow transplant,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
126,3,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
127,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
127,2,Complications of bone marrow transplant,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
127,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
127,4,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
128,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
128,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
129,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
129,2,Pneumonia adenoviral,Adenoviral infections,Viral infectious disorders,Infec,N
129,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
130,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
131,1,Angiotensin converting enzyme increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
131,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
131,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
131,4,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
131,5,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
131,6,Granuloma,Inflammations,General system disorders NEC,Genrl,N
131,7,Hepatic iron overload,Hepatic metabolic disorders,Hepatic and hepatobiliary disorders,Hepat,N
131,8,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
132,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
132,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
133,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
133,2,Myeloproliferative neoplasm,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
134,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,N
134,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
135,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
135,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
135,3,Myeloproliferative neoplasm,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
136,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,N
136,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
137,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
137,2,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
137,3,Graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
138,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,N
139,1,Myelodysplastic syndrome with excess blasts,Myelodysplastic syndromes,Leukaemias,Neopl,N
140,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
140,2,Myeloproliferative neoplasm,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
141,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
142,1,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
143,1,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
144,1,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
145,1,Cardiac tamponade,Pericardial disorders NEC,Pericardial disorders,Card,N
145,2,Pneumonia respiratory syncytial viral,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
145,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
145,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
146,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
146,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,Y
147,1,Enterobacter test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
147,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
148,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
149,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
150,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
151,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
152,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
153,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
154,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
155,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
156,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
156,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
157,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
157,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
157,3,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,Y
158,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
158,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
158,3,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
159,1,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,Y
160,1,Tooth hypoplasia,Dental disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
161,1,Tooth hypoplasia,Dental disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
162,1,Tooth hypoplasia,Dental disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
163,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
163,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
163,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
163,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
163,5,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
163,6,Idiopathic pneumonia syndrome,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
163,7,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
163,8,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
163,9,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
163,10,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
163,11,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
163,12,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
163,13,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
163,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
164,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
164,2,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
164,3,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
165,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
165,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
166,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
167,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
167,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
167,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
167,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
167,5,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
167,6,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
167,7,Idiopathic pneumonia syndrome,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
167,8,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
167,9,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
167,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
167,11,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
167,12,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
167,13,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
167,14,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
167,15,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
168,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
168,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
168,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
168,4,Idiopathic pneumonia syndrome,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
168,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
168,6,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
168,7,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
168,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
168,9,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
168,10,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
169,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
169,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
169,3,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
169,4,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
169,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
169,6,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
169,7,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
169,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
169,9,Refractoriness to platelet transfusion,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
169,10,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
169,11,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
169,12,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
170,1,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
170,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
171,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
171,2,Clostridial infection,Clostridia infections,Bacterial infectious disorders,Infec,N
171,3,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
171,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
171,5,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
172,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
172,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
172,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
173,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
173,2,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
173,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
174,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
174,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
175,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
176,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
176,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
176,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
176,4,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
177,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
178,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
179,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
179,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
180,1,Graves' disease,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
181,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
181,2,Traumatic lung injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
182,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
183,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
184,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
184,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
184,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
185,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
185,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
185,3,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
186,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
186,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
186,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
186,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
186,5,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
187,1,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,N
187,2,Lower respiratory tract infection fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
187,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
188,1,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
188,2,Pulmonary veno-occlusive disease,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
188,3,Right ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
188,4,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
188,5,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
189,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
189,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
189,3,Lower respiratory tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
189,4,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
190,1,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
190,2,Pulmonary veno-occlusive disease,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,Y
191,1,Disseminated Bacillus Calmette-Guerin infection,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
191,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
191,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
191,4,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
192,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
192,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
192,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
192,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
193,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
193,2,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
194,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
195,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
196,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,Y
197,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
197,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
197,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
197,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
197,5,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
198,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
198,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
198,3,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
199,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
200,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
200,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
200,3,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
201,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
201,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
201,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
201,4,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
202,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
202,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
202,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
202,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
202,5,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
203,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
204,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
205,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
206,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
207,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
207,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
207,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
207,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
207,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
207,6,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
208,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
208,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
209,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
209,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
209,3,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
209,4,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
209,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
209,6,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
209,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
210,1,Diarrhoea infectious,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
210,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,Y
210,3,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
210,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
210,5,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
210,6,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
210,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
210,8,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
211,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
211,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
211,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
211,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
211,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
211,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
211,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
211,8,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
211,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
212,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
212,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
212,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
212,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
212,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
212,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
212,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
212,8,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
212,9,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
212,10,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
213,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
213,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
213,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
213,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
213,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
213,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
213,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
213,8,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
213,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
214,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
214,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
214,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
214,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
214,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
214,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
214,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
214,8,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
214,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
215,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
215,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
215,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
215,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
215,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
215,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
215,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
215,8,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
215,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
216,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
216,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
217,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
217,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
218,1,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
218,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
218,3,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,N
219,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
220,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
221,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
222,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
223,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
224,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
225,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
226,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
226,2,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
226,3,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
227,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
228,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
229,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
230,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
231,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
232,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
232,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
233,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
234,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
234,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
234,3,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
234,4,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
234,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
235,1,Diarrhoea infectious,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
235,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,Y
235,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
235,4,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
235,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
235,6,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
236,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
236,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
236,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
236,4,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
236,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
236,6,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
236,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
237,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
237,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
238,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
239,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
239,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
239,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
240,1,Evans syndrome,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
240,2,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
240,3,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
241,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
241,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
241,3,Evans syndrome,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
241,4,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
241,5,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
241,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
242,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
242,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
242,3,Enterobacter bacteraemia,Enterobacter infections,Bacterial infectious disorders,Infec,N
242,4,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
242,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
242,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
242,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
243,1,Enterobacter bacteraemia,Enterobacter infections,Bacterial infectious disorders,Infec,N
243,2,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
244,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
244,2,Deafness,Hearing losses,Hearing disorders,Ear,N
244,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
244,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
244,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
245,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
245,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
246,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
246,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
246,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
247,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
247,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
247,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
248,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,Y
248,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
248,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
248,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
248,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
249,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
249,2,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,Y
250,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
250,2,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
251,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
251,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
251,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
252,1,Mycobacterium kansasii infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
252,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
253,1,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,Y
253,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
253,3,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
254,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
254,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
254,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
254,4,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
255,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
255,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
255,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
255,4,Pyloric stenosis,Gastric disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
255,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
255,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
256,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
256,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
256,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
257,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
257,2,Encephalomyelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
258,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
258,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
259,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
259,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
259,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
259,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
259,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
260,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
260,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
260,3,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
261,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
261,2,Mycobacterium kansasii infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
261,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
261,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
261,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
262,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
262,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
262,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
262,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
262,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
262,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
263,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
263,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
263,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
263,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
263,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
264,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
264,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
264,3,Early satiety,Feelings and sensations NEC,General system disorders NEC,Genrl,N
264,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
264,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
264,6,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
264,7,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
264,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
264,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
264,10,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
264,11,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
264,12,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
264,13,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
264,14,Serositis,Inflammations,General system disorders NEC,Genrl,N
264,15,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
265,1,Autoimmune pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
265,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
265,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
265,4,Large granular lymphocytosis,Leukaemias chronic T-cell,Leukaemias,Neopl,N
265,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
265,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
265,7,Pure white cell aplasia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
266,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
266,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
266,3,Autoimmune pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
266,4,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
266,5,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
266,6,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
266,7,Large granular lymphocytosis,Leukaemias chronic T-cell,Leukaemias,Neopl,N
266,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
267,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
268,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
269,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
270,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
271,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
272,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
273,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
274,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
275,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
276,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
277,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
278,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
279,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
280,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
281,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
281,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
282,1,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
282,2,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
282,3,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
282,4,Fibula fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
282,5,Fibula fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
282,6,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
282,7,Humerus fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
282,8,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
282,9,Nephrocalcinosis,Renal lithiasis,Urolithiases,Renal,N
282,10,Pathological fracture,Fractures NEC,Fractures,Musc,N
282,11,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
282,12,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
283,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
283,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
283,3,Ejection fraction,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
283,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
283,5,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
283,6,Latent tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
283,7,Left ventricular dilatation,Myocardial disorders NEC,Myocardial disorders,Card,N
283,8,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
283,9,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
283,10,Oxygen consumption increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
283,11,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
283,12,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
283,13,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
283,14,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
283,15,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
283,16,Systolic dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
284,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
284,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
284,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
285,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
285,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
286,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
287,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
287,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
287,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
287,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
287,5,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
287,6,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
287,7,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
287,8,Latent tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
287,9,Left ventricular dilatation,Myocardial disorders NEC,Myocardial disorders,Card,N
287,10,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
287,11,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
287,12,Oxygen consumption increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
287,13,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
287,14,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
287,15,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
287,16,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
287,17,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
287,18,Systolic dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
288,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
288,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
288,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
288,4,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
288,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
288,6,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
288,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
289,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,Y
289,2,Adenovirus reactivation,Adenoviral infections,Viral infectious disorders,Infec,N
289,3,Leukaemic infiltration pulmonary,Leukaemias NEC,Leukaemias,Neopl,N
289,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
289,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
290,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
290,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
290,3,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
290,4,Hypoglycaemia neonatal,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
290,5,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
290,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
290,7,Short stature,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
291,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
292,1,Clonal haematopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
292,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,Y
292,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
293,1,Acquired gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
293,2,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
293,3,Clonal haematopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
294,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
294,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
295,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
295,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
295,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
295,4,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
295,5,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
295,6,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
296,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
296,2,Pharyngeal inflammation,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
296,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
296,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
297,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
297,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
298,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
298,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
298,3,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
298,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
298,5,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
298,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
298,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
298,8,Short stature,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
299,1,Ovarian dysfunction,Female gonadal function disorders,Endocrine disorders of gonadal function,Endo,N
299,2,Tooth agenesis,Dental disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
300,1,Adenovirus reactivation,Adenoviral infections,Viral infectious disorders,Infec,N
300,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
301,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
302,1,Delayed puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
303,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
304,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
304,2,Hypogonadism,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
305,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
305,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
306,1,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
307,1,Delayed puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
308,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
308,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
308,3,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
308,4,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
308,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
308,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
308,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
308,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
309,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
309,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
309,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
309,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
309,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
310,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
310,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
310,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
310,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
311,1,Hypogonadism,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
311,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
312,1,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
312,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
313,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
313,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
313,3,Diarrhoea infectious,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
313,4,Enterobacter bacteraemia,Enterobacter infections,Bacterial infectious disorders,Infec,N
313,5,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
313,6,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
313,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
313,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
314,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
314,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
314,3,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
315,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
316,1,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
